임상시험용 바이오리포지토리 및 아카이브 솔루션 시장 : 규모, 점유율, 동향, 산업 분석 보고서 - 제품별, 서비스별, 위상별, 지역별 시장 예측(2024-2032년)
Clinical Trial Biorepository & Archiving Solutions Market Size, Share, Trends, Industry Analysis Report: By Product, By Service, By Phase, and By Region - Market Forecast, 2024-2032
샘플 요청 목록에 추가
Polaris Market Research의 최신 조사에 따르면 임상시험용 바이오 리포지토리 및 아카이브 솔루션 세계 시장 규모는 2032년까지 80억 9,000만 달러에 달할 전망입니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.
임상시험용 바이오리포지토리 및 아카이브 솔루션 시장은 임상시험 중에 수집된 생물학적 샘플 및 데이터의 보관, 관리, 보존을 위한 서비스 및 기술을 제공하는 의료 및 생명과학 산업 분야를 말합니다. 이 시장에는 혈액, 조직, DNA 및 기타 생물학적 물질과 같은 샘플을 처리하고 향후 연구 및 분석을 위해 완전성과 가용성을 보장하기 위해 설계된 다양한 솔루션이 포함됩니다. 의약품 개발에 대한 투자 증가와 생물학적 시료의 효율적인 관리에 대한 요구가 증가함에 따라 임상시험용 바이오 리포지토리 및 아카이브 솔루션 시장의 성장이 이어지고 있습니다. 기타 세계 임상시험 증가, 바이오뱅킹 기술 진보, 데이터 무결성 및 샘플 보존에 대한 규제 요건 증가 등이 시장 성장을 가속하고 있습니다.
맞춤형 의료에 대한 경사 증가, 유전체 연구에 대한 관심 증가, 샘플 추적 및 분석을 위한 AI와 자동화의 통합은 향후 몇 년동안 시장에 엄청난 기회를 제공할 것입니다. 시장에서는 중앙 집중식 바이오 리포지토리와 클라우드 기반 아카이브 솔루션으로의 전환이 진행되고 있어 접근성과 협업이 강화되고 있습니다. 전반적으로, 임상시험의 복잡성과 다양한 연구개발과 치료개발을 지원하는 견고한 바이오리포지토리 인프라의 필요성으로 시장이 크게 성장할 것으로 예상됩니다.
임상시험용 바이오 리포지토리 및 아카이브 솔루션 시장 보고서 하이라이트
제품별로, 임상 제품 분야는 임상시험용 바이오 리포지토리 및 아카이브 솔루션 시장을 독점하고 있습니다. 이는 임상시험 건수 증가와 의약품 개발의 다양한 단계에서의 고품질 샘플 관리에 대한 요구 증가에 기인합니다.
서비스별로는 생물 시료의 보관 및 관리에 중요한 역할을 하는 바이오 리포지토리 서비스가 시장을 독점하고 있습니다.
페이즈별로는 페이즈 III가 가장 높은 성장률을 보이고 있지만, 이는 유망한 신약 후보를 기업이 시장 승인과 상업화를 향해 진행하는 가운데, 이 단계에서의 임상시험 수가 증가하고 있는 것을 반영합니다.
북미는 광범위한 임상 연구 인프라와 바이오 리포지토리 솔루션에 대한 투자를 통해 세계 임상시험용 바이오 리포지토리 및 아카이브 솔루션 시장을 독점하고 있습니다. 그러나 아시아태평양은 신흥국에서의 임상시험 급증과 바이오리포지토리 투자 증가로 인해 가장 성장하고 있는 지역입니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 임상시험용 바이오 리포지토리 및 아카이브 솔루션 세계 시장 분석
시장 현황
임상시험용 바이오리포지토리 및 아카이브 솔루션 시장 역학
성장 촉진요인과 기회
자동 샘플 관리의 확대가 시장의 성장을 견인
데이터 분석과 통합에 대한 주목의 고조가 시장을 견인
억제요인과 과제
높은 운용 비용이 시장의 성장을 방해하고 있다
PESTEL 분석
임상시험용 바이오 리포지토리 및 아카이브 솔루션 시장의 용도 동향
밸류체인 분석
COVID-19의 영향 분석
제5장 세계의 임상시험용 바이오 리포지토리 및 아카이브 솔루션 시장 : 제품별
제6장 세계의 임상시험용 바이오 리포지토리 및 아카이브 솔루션 시장 : 서비스별
주요 조사 결과
소개
바이오 리포지토리 서비스
아카이브 솔루션 서비스
제7장 세계의 임상시험용 바이오 리포지토리 및 아카이브 솔루션 시장 : 단계별
주요 조사 결과
소개
전임상
페이즈 I
페이즈 II
페이즈 III
페이즈 IV
제8장 세계의 임상시험용 바이오 리포지토리 및 아카이브 솔루션 시장 :지역
주요 조사 결과
소개
임상시험용 바이오 리포지토리 및 아카이브 솔루션 시장 평가:지역, 2019-2032년
북미
북미 : 제품별, 2019-2032년
북미 : 서비스별, 2019-2032년
북미 : 페이즈별, 2019-2032년
미국
캐나다
유럽
유럽 : 제품별, 2019-2032년
유럽 : 서비스별, 2019-2032년
유럽 : 페이즈별, 2019-2032년
영국
프랑스
독일
이탈리아
스페인
네덜란드
러시아
기타 유럽
아시아태평양
아시아태평양: 제품별, 2019-2032년
아시아태평양: 서비스별, 2019-2032년
아시아태평양: 위상별, 2019-2032년
중국
인도
말레이시아
일본
인도네시아
한국
호주
기타 아시아태평양
중동 및 아프리카
중동 및 아프리카: 제품별, 2019-2032년
중동 및 아프리카 : 서비스별, 2019-2032년
중동 및 아프리카 : 페이즈별, 2019-2032년
사우디아라비아
아랍에미리트(UAE)
이스라엘
남아프리카
기타 중동 및 아프리카
라틴아메리카
라틴아메리카 : 제품별, 2019-2032년
라틴아메리카 : 서비스별, 2019-2032년
라틴아메리카 : 페이즈별, 2019-2032년
멕시코
브라질
아르헨티나
기타 라틴아메리카
제9장 경쟁 구도
제10장 기업 프로파일
Thermo Fisher Scientific
LabCorp
BioStorage Technologies
Brooks Life Sciences
QIAGEN
VWR International(part of Avantor)
Sartorius AG
Hamilton Company
NMDP BioTherapies
Precision Biobank
CryoPort
BioBanking Solutions
Celerion
STC Biologics
Pfizer(biorepository and archiving division)
Novartis(biorepository and archiving division)
JHS
The global clinical trial biorepository & archiving solutions market size is expected to reach USD 8.09 billion by 2032, according to a new study by Polaris Market Research. The report "Clinical Trial Biorepository & Archiving Solutions Market Size, Share, Trends, Industry Analysis Report: By Product (Preclinical Products and Clinical Products), By Service, By Phase, and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The clinical trial biorepository & archiving solutions market refers to the sector of the healthcare and life sciences industry that provides services and technologies for the storage, management, and preservation of biological samples and data collected during clinical trials. This market includes a range of solutions designed to handle samples such as blood, tissue, DNA, and other biological materials, ensuring their integrity and availability for future research and analysis. Increasing investments in drug development and growing need for efficient management of biological samples drive the clinical trial biorepository & archiving solutions market growth. Other factors such as a rise in clinical trials globally, advancements in biobanking technologies, and increase in regulatory requirements for data integrity and sample storage propel the market growth.
Rising inclination toward personalized medicine, increasing focus on genomic research, and the integration of AI and automation for sample tracking and analysis would provide vast opportunities for the market in the coming years. Emerging in the market are a shift toward centralized biorepositories and cloud-based archiving solutions, enhancing accessibility and collaboration. Overall, the market is expected to grow significantly, driven by the increasing complexity of clinical trials and the need for robust biorepository infrastructure to support diverse research and therapeutic developments.
Clinical Trial Biorepository & Archiving Solutions Market Report Highlights
By product, the clinical products segment dominates the clinical trial biorepository & archiving solutions market, driven by the increasing number of clinical trials and the rising need for high-quality sample management across various stages of drug development.
The biorepository services dominate the market, based on service type, due to their critical role in the storage and management of biological samples, essential for the growing number of clinical and research studies requiring extensive sample archiving.
In terms of phase, the phase III segment is witnessing the highest growth rate, reflecting the increasing number of trials in this phase as companies advance promising drug candidates toward market approval and commercialization.
North America dominates the global clinical trial biorepository & archiving solutions market, owing to its extensive clinical research infrastructure and investments in biorepository solutions. However, Asia Pacific is the highest growing region, driven by a surge in clinical trials and increase in biorepository investments in emerging economies.
Polaris Market Research has segmented the clinical trial biorepository & archiving solutions market report on the basis of product, service, phase, and region.
Clinical Trial Biorepository & Archiving Solutions, Product Outlook (Revenue - USD Billion, 2019-2032)
Preclinical Products
Clinical Products
Clinical Trial Biorepository & Archiving Solutions, Service Outlook (Revenue - USD Billion, 2019-2032)
Biorepository Services
Archiving Solution Services
Clinical Trial Biorepository & Archiving Solutions, Phase Outlook (Revenue - USD Billion, 2019-2032)
Preclinical
Phase I
Phase II
Phase III
Phase IV
Clinical Trial Biorepository & Archiving Solutions, Regional Outlook (Revenue - USD Billion, 2019-2032)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
3. Research Methodology
3.1. Overview
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Clinical Trial Biorepository & Archiving Solutions Market Insights
4.1. Clinical Trial Biorepository & Archiving Solutions Market - Market Snapshot
4.2. Clinical Trial Biorepository & Archiving Solutions Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Expansion of Automated Sample Management is Driving the Market Growth
4.2.1.2. Growing Focus On Data Analytics and Integration Propels the Market
4.2.2. Restraints and Challenges
4.2.2.1. High Operational Costs is Hindering the Market Growth
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Clinical Trial Biorepository & Archiving Solutions Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Clinical Trial Biorepository & Archiving Solutions Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
5.3. Preclinical Products
5.3.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Preclinical Products, by Region, 2019-2032 (USD Billion)
5.4. Clinical Products
5.4.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Clinical Products, by Region, 2019-2032 (USD Billion)
6. Global Clinical Trial Biorepository & Archiving Solutions Market, by Service Type
6.1. Key Findings
6.2. Introduction
6.2.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
6.3. Biorepository Services
6.3.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Biorepository Services, by Region, 2019-2032 (USD Billion)
6.4. Archiving Solution Services
6.4.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Archiving Solution Services, by Region, 2019-2032 (USD Billion)
7. Global Clinical Trial Biorepository & Archiving Solutions Market, by Phase
7.1. Key Findings
7.2. Introduction
7.2.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
7.3. Preclinical
7.3.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Preclinical, by Region, 2019-2032 (USD Billion)
7.4. Phase I
7.4.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Phase I, by Region, 2019-2032 (USD Billion)
7.5. Phase II
7.5.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Phase II, by Region, 2019-2032 (USD Billion)
7.6. Phase III
7.6.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Phase III, by Region, 2019-2032 (USD Billion)
7.7. Phase IV
7.7.1. Global Clinical Trial Biorepository & Archiving Solutions Market, by Phase IV, by Region, 2019-2032 (USD Billion)
8. Global Clinical Trial Biorepository & Archiving Solutions Market, by Geography
8.1. Key Findings
8.2. Introduction
8.2.1. Clinical Trial Biorepository & Archiving Solutions Market Assessment, By Geography, 2019-2032 (USD Billion)
8.3. Clinical Trial Biorepository & Archiving Solutions Market - North America
8.3.1. North America: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.3.2. North America: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.3.3. North America: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.3.4. Clinical Trial Biorepository & Archiving Solutions Market - U.S.
8.3.4.1. U.S.: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.3.4.2. U.S.: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.3.4.3. U.S.: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.3.5. Clinical Trial Biorepository & Archiving Solutions Market - Canada
8.3.5.1. Canada: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.3.5.2. Canada: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.3.5.3. Canada: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.4. Clinical Trial Biorepository & Archiving Solutions Market - Europe
8.4.1. Europe: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.4.2. Europe: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.4.3. Europe: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.4.4. Clinical Trial Biorepository & Archiving Solutions Market - UK
8.4.4.1. UK: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.4.4.2. UK: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.4.4.3. UK: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.4.5. Clinical Trial Biorepository & Archiving Solutions Market - France
8.4.5.1. France: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.4.5.2. France: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.4.5.3. France: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.4.6. Clinical Trial Biorepository & Archiving Solutions Market - Germany
8.4.6.1. Germany: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.4.6.2. Germany: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.4.6.3. Germany: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.4.7. Clinical Trial Biorepository & Archiving Solutions Market - Italy
8.4.7.1. Italy: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.4.7.2. Italy: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.4.7.3. Italy: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.4.8. Clinical Trial Biorepository & Archiving Solutions Market - Spain
8.4.8.1. Spain: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.4.8.2. Spain: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.4.8.3. Spain: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.4.9. Clinical Trial Biorepository & Archiving Solutions Market - Netherlands
8.4.9.1. Netherlands: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.4.9.2. Netherlands: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.4.9.3. Netherlands: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.4.10. Clinical Trial Biorepository & Archiving Solutions Market - Russia
8.4.10.1. Russia: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.4.10.2. Russia: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.4.10.3. Russia: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.4.11. Clinical Trial Biorepository & Archiving Solutions Market - Rest of Europe
8.4.11.1. Rest of Europe: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.4.11.2. Rest of Europe: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.4.11.3. Rest of Europe: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.5. Clinical Trial Biorepository & Archiving Solutions Market - Asia Pacific
8.5.1. Asia Pacific: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.5.2. Asia Pacific: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.5.3. Asia Pacific: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.5.4. Clinical Trial Biorepository & Archiving Solutions Market - China
8.5.4.1. China: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.5.4.2. China: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.5.4.3. China: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.5.5. Clinical Trial Biorepository & Archiving Solutions Market - India
8.5.5.1. India: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.5.5.2. India: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.5.5.3. India: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.5.6. Clinical Trial Biorepository & Archiving Solutions Market - Malaysia
8.5.6.1. Malaysia: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.5.6.2. Malaysia: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.5.6.3. Malaysia: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.5.7. Clinical Trial Biorepository & Archiving Solutions Market - Japan
8.5.7.1. Japan: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.5.7.2. Japan: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.5.7.3. Japan: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.5.8. Clinical Trial Biorepository & Archiving Solutions Market - Indonesia
8.5.8.1. Indonesia: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.5.8.2. Indonesia: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.5.8.3. Indonesia: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.5.9. Clinical Trial Biorepository & Archiving Solutions Market - South Korea
8.5.9.1. South Korea: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.5.9.2. South Korea: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.5.9.3. South Korea: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.5.10. Clinical Trial Biorepository & Archiving Solutions Market - Australia
8.5.10.1. Australia: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.5.10.2. Australia: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.5.10.3. Australia: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.5.11. Clinical Trial Biorepository & Archiving Solutions Market - Rest of Asia Pacific
8.5.11.1. Rest of Asia Pacific: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.5.11.2. Rest of Asia Pacific: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.5.11.3. Rest of Asia Pacific: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.6. Clinical Trial Biorepository & Archiving Solutions Market - Middle East & Africa
8.6.1. Middle East & Africa: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.6.2. Middle East & Africa: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.6.3. Middle East & Africa: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.6.4. Clinical Trial Biorepository & Archiving Solutions Market - Saudi Arabia
8.6.4.1. Saudi Arabia: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.6.4.2. Saudi Arabia: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.6.4.3. Saudi Arabia: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.6.5. Clinical Trial Biorepository & Archiving Solutions Market - UAE
8.6.5.1. UAE: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.6.5.2. UAE: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.6.5.3. UAE: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.6.6. Clinical Trial Biorepository & Archiving Solutions Market - Israel
8.6.6.1. Israel: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.6.6.2. Israel: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.6.6.3. Israel: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.6.7. Clinical Trial Biorepository & Archiving Solutions Market - South Africa
8.6.7.1. South Africa: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.6.7.2. South Africa: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.6.7.3. South Africa: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.6.8. Clinical Trial Biorepository & Archiving Solutions Market - Rest of Middle East & Africa
8.6.8.1. Rest of Middle East & Africa: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.6.8.2. Rest of Middle East & Africa: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.6.8.3. Rest of Middle East & Africa: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.7. Clinical Trial Biorepository & Archiving Solutions Market - Latin America
8.7.1. Latin America: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.7.2. Latin America: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.7.3. Latin America: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.7.4. Clinical Trial Biorepository & Archiving Solutions Market - Mexico
8.7.4.1. Mexico: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.7.4.2. Mexico: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.7.4.3. Mexico: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.7.5. Clinical Trial Biorepository & Archiving Solutions Market - Brazil
8.7.5.1. Brazil: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.7.5.2. Brazil: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.7.5.3. Brazil: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.7.6. Clinical Trial Biorepository & Archiving Solutions Market - Argentina
8.7.6.1. Argentina: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.7.6.2. Argentina: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.7.6.3. Argentina: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
8.7.7. Clinical Trial Biorepository & Archiving Solutions Market - Rest of Latin America
8.7.7.1. Rest of Latin America: Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2019-2032 (USD Billion)
8.7.7.2. Rest of Latin America: Clinical Trial Biorepository & Archiving Solutions Market, by Service Type, 2019-2032 (USD Billion)
8.7.7.3. Rest of Latin America: Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2019-2032 (USD Billion)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Thermo Fisher Scientific
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. LabCorp
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. BioStorage Technologies
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Brooks Life Sciences
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. QIAGEN
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. VWR International (part of Avantor)
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Sartorius AG
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Hamilton Company
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. NMDP BioTherapies
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Precision Biobank
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. CryoPort
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development
10.12. BioBanking Solutions
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Recent Development
10.13. Celerion
10.13.1. Company Overview
10.13.2. Financial Performance
10.13.3. Product Benchmarking
10.13.4. Recent Development
10.14. STC Biologics
10.14.1. Company Overview
10.14.2. Financial Performance
10.14.3. Product Benchmarking
10.14.4. Recent Development
10.15. Pfizer (biorepository and archiving division)
10.15.1. Company Overview
10.15.2. Financial Performance
10.15.3. Product Benchmarking
10.15.4. Recent Development
10.16. Novartis (biorepository and archiving division)
10.16.1. Company Overview
10.16.2. Financial Performance
10.16.3. Product Benchmarking
10.16.4. Recent Development